CTMX

CYTOMX THERAPEUTICS INC

Healthcare | Small Cap

-$0.13

EPS Forecast

$4.79

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.13

Revenue Forecast:

$4.79

EPS Surprise Forecast:

-$0.002

Revenue Surprise Forecast:

$0

Post-release price volatility - Very high

Post-release Overnight Move:

±11.6%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

49%

Probability of beating revenue consensus:

56%

Probability of beating both EPS & revs consensus:

34%

Probability of missing both EPS & revs consensus:

29%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.08

Revenue standard deviation:

$4

As % of share price:

1.65% HIGH

As % of market cap:

0.51% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.03

Revenue 95th %ile:

$10

EPS 75th %ile:

-$0.11

Revenue 75th %ile:

$6

EPS 25th %ile:

-$0.16

Revenue 25th %ile:

$4

EPS 5th %ile:

-$0.23

Revenue 5th %ile:

$1

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$25

Bid-ask per Share:

$0.01